Callori Fred 4
4 · Landos Biopharma, Inc. · Filed Jun 9, 2022
Insider Transaction Report
Form 4
Callori Fred
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-07+18,000→ 18,000 totalExercise: $0.91Exp: 2032-06-06→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest and become exercisable on June 7, 2023, subject to the Reporting Person providing continuous service through such date.